What is Bioxytran Inc?
, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 4.10M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.